Go Pro
→ Buffett's Final Warning: 'The Dollar Is Going to Hell' (From Decentralized Masters) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
$0.53
+8.9%		$0.75
$0.43
▼
$2.89
$1.43M0.89157,681 shs374,534 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.01
$0.04
▼
$0.19
$653K0.311,976 shsN/A
Profusa, Inc. stock logo
PFSA
Profusa
$2.18
+0.2%		$4.79
$1.58
▼
$3,000.00
$1.33M0.49453,734 shs1.53 million shs
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
$0.05
-7.8%		$0.07
$0.02
▼
$7.72
$322K1.8666,508 shs92,024 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
+1.93%-10.20%-22.56%-64.08%-77.34%
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%0.00%0.00%0.00%-88.35%
Profusa, Inc. stock logo
PFSA
Profusa
+11.86%+18.58%-60.26%-83.31%+216,999,900.00%
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
+33.15%+63.33%+22.50%-77.73%-99.18%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
$0.53
+8.9%		$0.75
$0.43
▼
$2.89
$1.43M0.89157,681 shs374,534 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.01
$0.04
▼
$0.19
$653K0.311,976 shsN/A
Profusa, Inc. stock logo
PFSA
Profusa
$2.18
+0.2%		$4.79
$1.58
▼
$3,000.00
$1.33M0.49453,734 shs1.53 million shs
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
$0.05
-7.8%		$0.07
$0.02
▼
$7.72
$322K1.8666,508 shs92,024 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
+1.93%-10.20%-22.56%-64.08%-77.34%
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%0.00%0.00%0.00%-88.35%
Profusa, Inc. stock logo
PFSA
Profusa
+11.86%+18.58%-60.26%-83.31%+216,999,900.00%
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
+33.15%+63.33%+22.50%-77.73%-99.18%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
1.00
SellN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
Profusa, Inc. stock logo
PFSA
Profusa
1.00
SellN/AN/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
1.50
ReduceN/AN/A

Current Analyst Ratings Breakdown

Latest RBOT, BBLG, PFSA, and DYNT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2026
Profusa, Inc. stock logo
PFSA
Profusa
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
8/14/2026
Profusa, Inc. stock logo
PFSA
Profusa
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (E+) ➝ Sell (E)
7/24/2026
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/24/2026
Profusa, Inc. stock logo
PFSA
Profusa
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/A$3.00 per shareN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.00N/AN/A$0.57 per share0.00
Profusa, Inc. stock logo
PFSA
Profusa
$100K13.27N/AN/A($2,168.90) per share0.00
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
N/AN/AN/AN/A$7.89 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$3.11M-$1.37N/AN/AN/AN/A-57.87%-53.65%11/13/2026 (Estimated)
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$1.35N/AN/AN/A-8.35%-41.81%-9.56%N/A
Profusa, Inc. stock logo
PFSA
Profusa
-$35.82M-$5,619.96N/AN/AN/AN/AN/A-1,731.09%N/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
-$63.22M-$6.69N/AN/AN/AN/A-184.13%-112.50%11/17/2026 (Estimated)

Latest RBOT, BBLG, PFSA, and DYNT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/19/2026Q2 2026
Profusa, Inc. stock logo
PFSA
Profusa
N/A-$151.80N/A-$151.80N/AN/A
8/14/2026Q2 2026
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$0.39-$0.43-$0.04-$0.43N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
Profusa, Inc. stock logo
PFSA
Profusa
N/AN/AN/AN/AN/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/A
8.67
8.67
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
Profusa, Inc. stock logo
PFSA
Profusa
N/A
0.03
0.03
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
N/A
4.75
4.75

Institutional Ownership

CompanyInstitutional Ownership
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
34.30%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
Profusa, Inc. stock logo
PFSA
Profusa
9.81%
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
47.27%

Insider Ownership

CompanyInsider Ownership
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
5.00%
Dynatronics Co. stock logo
DYNT
Dynatronics
2.90%
Profusa, Inc. stock logo
PFSA
Profusa
15.00%
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
11.11%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
22.76 million2.62 millionNot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20016.05 million8.11 millionNot Optionable
Profusa, Inc. stock logo
PFSA
Profusa
2610,000515,000N/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
2107.12 million5.89 millionNo Data

Recent News About These Companies

SRS 2026 recap: The biggest surgical robot stories of the last week
July 29, 2026  |  massdevice.comhttps://www.massdevice.com/srs-2026-biggest-surgical-robot-stories/
Time runs out for Vicarious Surgical
July 23, 2026  |  medtechdive.comM
Vicarious Surgical Loses Fight to Survive as Shareholders Approve Dissolution
July 22, 2026  |  mddionline.comM
Vicarious Surgical officially shutting down
July 21, 2026  |  therobotreport.comT
Another SPAC Failure: Vicarious Surgical Board Recommends Company Dissolution
July 17, 2026  |  mddionline.comM
Vicarious Surgical’s board wants to shut down and liquidate robotics developer
July 17, 2026  |  massdevice.comhttps://www.massdevice.com/vicarious-surgical-shut-down-liquidation-robotics-developer/
SS Innovations names Sarah Romano as CFO
July 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ss-innovations-names-sarah-romano-050351131.html
Vicarious Surgical board seeks to dissolve company
July 15, 2026  |  therobotreport.comT
Vicarious Surgical board proposes dissolving the company
July 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vicarious-surgical-board-proposes-dissolving-163333250.html
Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting
May 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/13/3294032/0/en/vicarious-surgical-demonstrates-sustained-system-performance-and-complex-hernia-procedure-workflows-in-pre-clinical-setting.html
Vicarious Surgical Reports First Quarter 2026 Financial Results
April 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/30/3284842/0/en/vicarious-surgical-reports-first-quarter-2026-financial-results.html
Vicarious Surgical Shareholders Approve Reverse Stock Split Authorization
April 8, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vicarious-surgical-shareholders-approve-reverse-stock-split-authorization?utm_source=marketbeat.com&utm_medium=referral
Vicarious Surgical, Inc. Class A
April 7, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/RBOT
Vicarious Surgical completes testing milestone for surgical robot
March 30, 2026  |  massdevice.comhttps://www.massdevice.com/vicarious-completes-testing-milestone-surgical-robot/
Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair
March 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/30/3265022/0/en/vicarious-surgical-completes-integrated-benchtop-testing-of-full-surgical-instrument-suite-for-ventral-hernia-repair.html
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing
March 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/25/3262594/0/en/vicarious-surgical-begins-quotation-on-the-otcqb-as-part-of-strategic-path-toward-potential-nasdaq-listing.html
‘Why do we exist?’: Inside Stephen From’s business strategy to get Vicarious Surgical to the finish line
March 20, 2026  |  massdevice.comhttps://www.massdevice.com/vicarious-surgical-ceo-stephen-from-strategy-for-success/
Vicarious Fights to Stay Afloat & Other Medtech News
March 19, 2026  |  mddionline.comM
This surgical robotics company sees opportunity in hernia repair
March 19, 2026  |  medicaldesignandoutsourcing.comM
Vicarious Surgical pursues Nasdaq listing, cuts cash burn to $19M
March 16, 2026  |  massdevice.comhttps://www.massdevice.com/vicarious-surgical-pursues-nasdaq-listing/

Media Sentiment Over Time

Top Headlines

View All Headlines
Data center hallway with rows of server racks and cables, plus a monitoring room with computer screens in the background.
AI Token Costs Are Changing the Hardware vs. Software Debate
By Jeffrey Neal Johnson | September 6, 2026
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
A Tesla concept vehicle with illuminated front light bar drives on a road against a city skyline at dusk.
Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
By Sam Quirke | September 8, 2026
Gold-colored concept electric vehicle with a smooth, minimalist body parked outdoors near a building and tree.
Ride-Share Reckoning: Tesla Drives Into Uber's Lane
By Jeffrey Neal Johnson | September 7, 2026
Intuit logo displayed over a desk with a laptop, coffee mug, notebook, plant, and financial chart printout.
Intuit’s Earnings Reset May Be More Pivot Than Plunge
By Jeffrey Neal Johnson | August 28, 2026
Bone Biologics stock logo

Bone Biologics NASDAQ:BBLG

$0.53 +0.04 (+8.89%)
As of 02:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Profusa stock logo

Profusa NASDAQ:PFSA

$2.17 +0.01 (+0.23%)
As of 02:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.

Vicarious Surgical stock logo

Vicarious Surgical NYSE:RBOT

$0.05 0.00 (-7.76%)
As of 02:32 PM Eastern

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas